Technology | September 22, 2008

InTempo Adaptive Imaging System Addresses Prostate Motion

Accuray's InTempo Adaptive Imaging System enhances the CyberKnife Robotic Radiosurgery System’s ability to continually track and correct for motion of the prostate during treatment.

Studies have confirmed that the prostate can move significantly in only a matter of seconds during treatment delivery. With the introduction of the InTempo System, radiation delivery with the CyberKnife System automatically adapts to patient-specific intra-fraction prostate motion. By intelligently increasing imaging frequency during periods of rapid and erratic prostate movement, the CyberKnife System reportedly tailors treatment delivery uniquely to the movements of the prostate throughout the treatment session. This continual assessment of prostate motion combined, with the CyberKnife System’s automatic correction for movement in real time, not only helps to ensure prescribed doses are delivered to the prostate; it also helps to ensure surrounding sensitive structures are maximally spared.

With conventional radiation delivery techniques, such as 3D conformal and arcing IMRT, large treatment margins are commonly used to ensure adequate dose coverage in the event a potential prostate shift occurs. This additional dose coverage often encompasses regions of the rectum, bladder and urethra, increasing the risks of related toxicities and complications.

September 2008

Related Content

more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | July 05, 2017
A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to evaluate the...
ASTRO Issues Guideline for Stereotactic Radiation Use in Early-Stage Lung Cancer
Feature | Lung Cancer | June 23, 2017
The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the use of...
stereotactic body radiation therapy (SBRT)
News | Stereotactic Body Radiation Therapy (SBRT) | June 12, 2017
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of stereotactic body...
Stereotactic Radiation Highly Effective for Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | May 03, 2017
Kidney cancer patients may soon have an alternative to traditional treatments, according to new research at UT...
SBRT, stereotactic body radiation therapy, early-stage lung cancer, patients 80 and older, 2017 Multidisciplinary Thoracic Cancers Symposium, study
News | Stereotactic Body Radiation Therapy (SBRT) | March 20, 2017
Patients in their 80s and 90s who have early-stage lung cancer but cannot undergo an operation can be treated safely...
prostate cancer, partial gland, SBRT, clinical trial, UH Hospitals
News | Stereotactic Body Radiation Therapy (SBRT) | April 28, 2016
Physicians at University Hospitals Seidman Cancer Center (Cleveland) have started a clinical trial using a new form of...
prostate cancer, stereotactic body radiation therapy, SBRT, cure rate, UT Southwestern Study
News | Prostate Cancer | April 19, 2016
A five-year study shows that stereotactic body radiation therapy (SBRT) offers a higher cure rate for prostate cancer...
Overlay Init